Literature DB >> 528377

Studies on bacterial cell wall inhibitors. VII. Azureomycins A and B, new antibiotics produced by Pseudonocardia azurea nov. sp. Taxonomy of the producing organism, isolation, characterization and biological properties.

S Omura, H Tanaka, Y Tanaka, P Spiri-Nakagawa, R Oiwa, Y Takahashi, K Matsuyama, Y Iwai.   

Abstract

Two new basic water-soluble antibiotics, azureomycins A and B, were isolated from the culture broth of an actinomycete, strain AM-3696, designated as Pseudonocardia azurea nov. sp. The antibiotics exhibit moderate antimicrobial activities against Gram-positive bacteria including penicillin-resistant Staphylococcus, Mycobacterium and Clostridium. They inhibit the synthesis of bacterial cell wall peptidoglycan.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528377     DOI: 10.7164/antibiotics.32.985

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  Philosophy of new drug discovery.

Authors:  S Omura
Journal:  Microbiol Rev       Date:  1986-09

2.  Optimization of Culturing Conditions for Improved Production of Bioactive Metabolites by Pseudonocardia sp. VUK-10.

Authors:  Mangamuri Usha Kiranmayi; Poda Sudhakar; Kamma Sreenivasulu; Muvva Vijayalakshmi
Journal:  Mycobiology       Date:  2011-09-27       Impact factor: 1.858

3.  Genome sequencing and annotation of Amycolatopsis azurea DSM 43854(T).

Authors:  Indu Khatri; Srikrishna Subramanian; Shanmugam Mayilraj
Journal:  Genom Data       Date:  2014-03-12

4.  Isolation and biological evaluation of N-(4-aminocyclooctyl)-3, 5-dinitrobenzamide, a new semisynthetic derivative from the Mangrove-associated actinomycete Pseudonocardia endophytica VUK-10.

Authors:  Usha Kiranmayi Mangamuri; Muvva Vijayalakshmi; Sudhakar Poda; Bramanandam Manavathi; Bhujangarao Chitturi; Venkateswarlu Yenamandra
Journal:  3 Biotech       Date:  2016-07-27       Impact factor: 2.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.